ArticleJournal of managed care & specialty pharmacy2025

Assessing variation in US payer coverage of anti-vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edema.

James D Chambers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.